Das Klinikum Neumarkt ist ein Klinikum in Neumarkt in der Oberpfalz, welches vom Landkreis Neumarkt durch die Kliniken des Landkreises Neumarkt i.d.OPf. als Kommunalunternehmen betrieben wird. Es ist als Krankenhaus der Versorgungsstufe II klassifiziert.

During the past decade, Klinikum Neumarkt conducted 4 clinical trials. In the 10-year time frame, 4 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Klinikum Neumarkt" #1 sponsor was "German High-Grade Non-Hodgkin's Lymphoma Study Group" with 3 trials, followed by "AGO Research GmbH" with 2 trials sponsored, "AGO Study Group" with 2 trials sponsored, "Arcagy Research" with 1 trials sponsored and "Queen Mary University of London" with 1 trials sponsored. Other sponsors include -4 different institutions and companies that sponsored additional 6 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Klinikum Neumarkt" #1 collaborator was "Arbeitsgemeinschaft Gynaekologische Onkologie Austria" with 3 trials as a collaborator, "ARCAGY/ GINECO GROUP" with 1 trials as a collaborator, "Arbeitsgemeinschaft Gynaekologishe Onkologie Germany" with 1 trials as a collaborator, "AstraZeneca" with 1 trials as a collaborator and "Australia New Zealand Gynaecological Oncology Group" with 1 trials as a collaborator. Other collaborators include 5 different institutions and companies that were collaborators in the rest 15 trials.

According to Clinical.Site data, the most researched conditions in "Klinikum Neumarkt" are "Lymphoma" (3 trials), "Ovarian Cancer" (3 trials), "Breast Cancer" (1 trials), "Estrogen Receptor Positive Breast Cancer" (1 trials) and "Fallopian Tube Cancer" (1 trials). Many other conditions were trialed in "Klinikum Neumarkt" in a lesser frequency.

Most popular intervention types in "Klinikum Neumarkt" are "Drug" (8 trials), "Biological" (4 trials), "Radiation" (3 trials), "Combination Product" (1 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Bevacizumab" (3 trials), "Carboplatin" (3 trials), "cyclophosphamide" (3 trials), "doxorubicin hydrochloride" (3 trials) and "prednisone" (3 trials). Other intervention names were less common.

The vast majority of trials in "Klinikum Neumarkt" are 7 trials for "Female" genders and 3 trials for "All" genders.

Currently, there are NaN active trials in "Klinikum Neumarkt". undefined are not yet recruiting, 1 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 7 completed trials in Klinikum Neumarkt, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Klinikum Neumarkt, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 7 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".